Target intelligence / Profile preview

Vomeronasal type-1 receptor 106 pseudogene (VN1R106P)

Target
VN1R106P
Molecular classification
G protein-coupled receptor (pseudogene), Receptor (pseudogene), Chemosensory receptor (pseudogene)
01

Overview

Vomeronasal type-1 receptor 106 pseudogene (VN1R106P, FKSG41) is a member of the vomeronasal type-1 receptor family in humans but is classified as a pseudogene. Vomeronasal receptors (V1Rs) are G protein-coupled receptors (GPCRs) implicated in pheromone detection in most mammals. In humans, most V1R genes, including VN1R106P, are pseudogenized and believed to be nonfunctional, lacking expression or protein-coding capability. Therefore, VN1R106P is not considered a therapeutic target, and there are no known drugs or established disease associations for this pseudogene. The vomeronasal receptor system is mostly nonfunctional in humans due to pseudogenization, particularly in the Catarrhini (Old World monkeys and apes, including humans), where the vomeronasal organ and its associated signaling functions have largely regressed. VN1R106P is specifically listed as a pseudogene and not as a functional receptor in genomic and product databases, with no evidence of a coding protein or physiological function in humans. The broader V1R family is part of the GPCR "chemosensory" superfamily involved in pheromone signaling in other mammals, but in humans, most members are pseudogenes with no actionable or therapeutic significance. No interacting drugs, biomarkers, or disease associations are described for VN1R106P, as is typical for nonfunctional pseudogenes. While related genes in other species serve sensory/behavioral functions (pheromone detection), this is not the case for human pseudogenes of the family.

Other names
FKSG41VN1R106PENSG00000268593
02

Biological functions

Other (pseudogene: no active biological function)
03

Disease associations

Other (no established role in disease)

Beyond the preview

Go deeper on Vomeronasal type-1 receptor 106 pseudogene (VN1R106P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vomeronasal type-1 receptor 106 pseudogene (VN1R106P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call